Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRA | P10827 | 4/20 | 0.65 |
| ▸ | THRB | P10828 | 4/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | SMPD1 | P17405 | 4/20 | 0.50 |
| ▸ | PLA2G2D | Q9UNK4 | 1/20 | 0.50 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.50 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.48 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.48 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.48 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.48 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9428136 | 1.00 | THRA (0.65) | THRATHRBALDH1A1HPGDSMPD1 | |
| SCHEMBL9626600 | 1.00 | THRA (0.65) | THRATHRBALDH1A1HPGDSMPD1 | |
| SCHEMBL9626635 | 1.00 | THRA (0.65) | THRATHRBALDH1A1HPGDSMPD1 | |
| SCHEMBL10527065 | 1.00 | THRA (0.65) | THRATHRBALDH1A1HPGDSMPD1 | |
| SCHEMBL10359036 | 0.89 | PTPN11 (0.58) | THRATHRBALDH1A1HPGDSMPD1 | |
| SCHEMBL9440582 | 0.89 | PTPN11 (0.58) | THRATHRBALDH1A1HPGDSMPD1 | |
| SCHEMBL9650967 | 0.89 | PTPN11 (0.58) | THRATHRBALDH1A1HPGDSMPD1 | |
| SCHEMBL9440043 | 0.88 | THRA (0.68) | THRATHRBALDH1A1HPGDPLA2G2D | |
| SCHEMBL9437150 | 0.88 | THRA (0.68) | THRATHRBALDH1A1HPGDPLA2G2D | |
| SCHEMBL9440284 | 0.88 | THRA (0.68) | THRATHRBALDH1A1HPGDPLA2G2D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102993017-B | optically active additive, liquid crystal formula and forming method thereof, and liquid crystal display | IND TECH RES INST | 2015-04-29 | — | — | CN | disclosed |
| US-8449953-B2 | Chiral dopants, liquid crystal matrix and manufacturing method thereof and liquid crystal display | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2013-05-28 | — | — | US | disclosed |
| CN-102993017-A | Optically active additive, liquid crystal formula and forming method thereof, and liquid crystal display | IND TECH RES INST | 2013-03-27 | — | — | CN | disclosed |
| US-20130063693-A1 | CHIRAL DOPANTS, LIQUID CRYSTAL MATRIX AND MANUFACTURING METHOD THEREOF AND LIQUID CRYSTAL DISPLAY | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2013-03-14 | — | — | US | disclosed |
| EP-0335348-B2 | Mesomorphic compound, ferroelectric liquid crystal composition containing same and ferroelectric liquid crystal device | CANON KK (JP) | 2002-02-27 | — | — | EP | disclosed |
| EP-0335348-B1 | Mesomorphic compound, ferroelectric liquid crystal composition containing same and ferroelectric liquid crystal device | CANON KK (JP) | 1996-03-20 | — | — | EP | disclosed |
| EP-0418922-B1 | Mesomorphic compound, liquid crystal composition containing same and liquid crystal device using same | CANON KK (JP) | 1995-04-12 | — | — | EP | disclosed |
| EP-0315193-B1 | Optically active compound and chiral liquid crystal composition containing the same | NIPPON TELEGRAPH & TELEPHONE (JP) | 1994-04-06 | — | — | EP | disclosed |
| US-5200109-A | 4-substituted-3-fluorophenyl-thiadiazole derivatives; high speed responsiveness, heat resistance, displaying | CANON KABUSHIKI KAISHA (JP) | 1993-04-06 | — | — | US | disclosed |
| EP-0188222-B1 | NOVEL LIQUID CRISTALLINE COMPOUNDS HAVING SUBSTITUENTS | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1992-04-29 | — | — | EP | disclosed |
| US-5059345-A | Spontaneous polarization in wide temperature range and high speed response | NIPPON TELEGRAPH AND TELEPHONE CORPORATION (JP) | 1991-10-22 | — | — | US | disclosed |
| US-5034151-A | Laminate with 1,3,4-oxadiazole compoumd as liquid crystal | CANON KABUSHIKI KAISHA (JP) | 1991-07-23 | — | — | US | disclosed |
| EP-0418922-A2 | Mesomorphic compound, liquid crystal composition containing same and liquid crystal device using same | CANON KABUSHIKI KAISHA (JP) | 1991-03-27 | — | — | EP | disclosed |
| US-4943386-A | FERROELECTRIC, GOOD RESPONSE AND MEMORY | DAINIPPON INK & CHEMICALS, INC. (JP) | 1990-07-24 | — | — | US | disclosed |
| EP-0335348-A2 | Mesomorphic compound, ferroelectric liquid crystal composition containing same and ferroelectric liquid crystal device | CANON KABUSHIKI KAISHA (JP) | 1989-10-04 | — | — | EP | disclosed |
| EP-0315193-A2 | Optically active compound and chiral liquid crystal composition containing the same | NIPPON TELEGRAPH AND TELEPHONE CORPORATION (JP) | 1989-05-10 | — | — | EP | disclosed |
| US-4828754-A | TILT-TYPE CHIRAL SMECTIC PHASE | DAINIPPON INK & CHEMICALS, INC. (JP) | 1989-05-09 | — | — | US | disclosed |
| EP-0256303-A2 | Liquid crystal compounds having fluorine-containing core | POLAROID CORPORATION (US) | 1988-02-24 | — | — | EP | disclosed |
| EP-0188222-A2 | Novel liquid cristalline compounds having substituents | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1986-07-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130063693-A1 | CHIRAL DOPANTS, LIQUID CRYSTAL MATRIX AND MANUFACTURING METHOD THEREOF AND LIQUID CRYSTAL DISPLAY | CNPY2, YBX3, CCR3 | THRA 2832/4885THRB 2863/4885ALDH1A1 3647/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.